Skip to main content
Frontiers in Public Health logoLink to Frontiers in Public Health
. 2025 May 23;13:1514812. doi: 10.3389/fpubh.2025.1514812

Mental health of airline pilots in France: insights from an anonymous online survey

Madeleine Percheron 1,*, Bernard Prouvost-Keller 1, Jonathan Allouche 1, Michel Benoit 2, Christian Pradier 3
PMCID: PMC12142686  PMID: 40487533

Abstract

Background

The German wings crash highlighted the need to better understand the mental health of airline pilots. Airline pilots are exposed to psychosocial risks, and they may constitute a population at risk of developing anxiety and depressive disorders. However, mental health remains difficult to assess in this population due to the risk of being declared unfit to fly. Scientific studies on mental disorders in airline pilots are rare, and the results are heterogeneous. To date, no study has been conducted describing anxiety or depressive disorders among European airline pilots.

Method

We conducted a descriptive cross-sectional study using an anonymous online self-questionnaire. Pilots were recruited from the National Union of Airline Pilots between September 1 and October 16, 2022.

Findings

Out of the 1,220 pilots surveyed, 25.4% of them suffered from anxiety according to the Hospital and Depression Scale (HAD): 14.4% suspected anxiety disorders and 11.0% confirmed anxiety disorders. Additionally, 13.1% of subjects reported depressive symptoms, including 8.9% suspected depressive disorders and 4.2% confirmed depressive disorders, according to the HAD. More than a third of the sample (40.1%) showed alcohol misuse.

Interpretation

This study represents a major advancement in understanding the mental health of European airline pilots. This work highlights the need to implement prevention programs targeting profiles at risk of developing anxiety and/or depressive disorders. Our study also showed that a large proportion of subjects exhibited alcohol misuse, which requires prevention efforts to reduce health risks. In the future, conducting longitudinal studies would further strengthen our knowledge on this topic.

Keywords: depressive disorder, anxiety disorder (AD), mental health, alcohol consumption, airline pilots, aviation medicine, suicidal thought

1. Introduction

1.1. Background

The crash of Germanwings Flight in March 2015 was caused by the suicide of the copilot. The cause of the accident was determined retrospectively by the experts of the Bureau d’Enquêtes et d’Analyses (BEA). This copilot had been suffering from severe depression for several weeks and had not informed the airline about it (1). This is not an isolated event. Other similar cases of suicides while in command have been described in aviation records, such as the crash of EgyptAir Flight 990 in 1999 and the crash of SilkAir Flight 185 in 1997 (2). The mental health of airline pilots is therefore a variable that can pose risks to aviation safety.

The International Civil Aviation Organization mandates that airline pilots undergo a specialized medical examination aimed at eliminating any somatic and/or psychiatric contra-indication to practice this profession. It is carried out in approved centres for aviation medicine. Aviation medical examiners (AME) are the only ones authorized to issue the medical fitness of airline pilots, or Class 1 medical certificate, which must be renewed every year (3).

According to the recommendations of the European Aviation Safety Agency (EASA), anxiety and depressive disorders are grounds for suspension of medical fitness (3).

Airline pilots are exposed to psychosocial risks and they may constitute a population at risk of developing anxiety and depressive disorders (4). However, mental health remains difficult to assess in this population due to the likelihood of being declared unfit by the AME (3). This leads to a under-reporting of psychological symptoms and the use of psychotropic treatments during medical fitness examinations (5–7).

Despite these concerns, research on the mental health of airline pilots remains limited, with heterogeneous results (8). According to the latest figures from 2018, there were 7,642 active airline pilots in France (9). The National Union of Airline Pilots (SNPL) represents the main pilot union in France, encompassing all airlines. Its membership rate reaches approximately 77% of employed pilots in France (10), which represents one of the largest national databases concerning them.

Existing studies highlight the role of occupational stress in pilots’ health outcomes (4), but large-scale data on anxiety and depressive disorders in European airline pilots are lacking.

1.2. Study objectives

Therefore, we aimed to describe the mental health of airline pilots by assessing anxiety and depressive dimensions, as well as the socio-demographic, professional factors, and potential comorbidities associated with them.

2. Materials and methods

2.1. Study design and participant recruitment

We conducted a descriptive cross-sectional study using an anonymous online self-survey. A link to the questionnaire was emailed to all SNPL members between September 1 and October 16, 2022, through the Drag’n Survey platform. The questionnaire was available in both French and English.

2.2. Questionnaire

The questionnaire included socio-demographic, professional, and medical data. Standardised and validated scales in both French and English were used to evaluate anxiety and depressive symptoms (Hospital Anxiety and Depression Scale, HAD-S) (11), personal alcohol consumption (Alcohol Use Disorder Identification Test-Concise) (12), and cannabis use (Cannabis Abuse Screening Test) (13).

2.2.1. Hospital Anxiety and Depression Scale (HAD-S)

The HAD-S is an assessment scale for anxiety and depressive symptoms experienced in the past week. It consists of two subscales: one evaluating the depressive dimension and the other the anxious dimension. For each subscale, the interpretation is as follows: < 8: absence of symptoms, 8 to 10: suspected disorder, and > 10: confirmed disorder. This tool allows for the identification of anxiety symptoms with a sensitivity of 72% and a specificity of 96% (HAD-A). Similarly, it allows for the evaluation of depressive states with a sensitivity of 82% and a specificity of 92% (HAD-D) (11).

2.2.2. Alcohol Use Disorder Identification Test-Concise (AUDIT-C)

The AUDIT-C is a validated scale for diagnosing alcohol misuse with a sensitivity of 86% and a specificity of 72%. It consists of 3 questions. A total score of 4 or higher for men and 3 for women suggests alcohol misuse. A score above 10 in both sexes should raise suspicion of dependence (12).

2.2.3. Cannabis Abuse Screening Test (CAST)

The CAST is a tool for identifying cannabis misuse. Users are classified as low risk when they score below 3, as moderate risk when they score between 3 and 7, and as high risk for dependence when they score equal to or above 7 (13).

2.3. Outcome measures

The primary outcome measure was to determine anxiety and depression scores using the HAD-S scale.

The secondary outcome measure was to describe and measure the association of commonly found co-factors in anxiety and depressive disorders, including socio-demographic and occupational characteristics, health data, and alcohol and cannabis use.

2.4. Statistical analysis

We used JAMOVI software for data analysis. For continuous variables, t-test or Mann–Whitney test were chosen based on normality assumption. We used chi-square/Fisher’s exact tests for univariate analysis for anxiety or depression and the logistic regression model included participant numbers, univariate factors, and other relevant influences on anxiety or depression, maintaining a 5% alpha risk. Significance was defined as p-value <0.05.

3. Results

3.1. Participation description

We received 1,276 questionnaires, and 1,220 (95.6%) were included (56 responses were not considered in the analysis: 55 questionnaires reported an age equal to or older than 65 years, the age limit for practice, and 1 questionnaire was not usable).

3.2. Participant characteristics

3.2.1. Socio-demographic characteristics

Out of the 1,220 participating pilots, 1,139 (93.3%) were of French nationality. We had 1,109 (90.9%) male participants, and the average age was 45.4 years. Among all respondents, 961 (78.8%) were in a relationship, and 868 (71.1%) had at least one child. Regarding the mention of financial difficulties, 180 (14.7%) reported experiencing them (Table 1).

Table 1.

Socio-demographic characteristics.

Subjects (N = 1,220)
Gender Female 111 (9.1)
Male 1,109 (90.9)
Age Mean (standard-deviation or SD) 45.4 (9.8)
Nationality France 1,139 (93.3)
Europe (except France) 74 (6.1)
Missing datas 7 (0.6)
Children Yes 868 (71.1)
No 335 (27.5)
Missing datas 17 (1.4)
Financial difficulties Yes 180 (14.7)
No 907 (74.3)
Missing datas 133 (11)
Marital status In a relationship 961 (78.8)
Single 242 (19.8)
Missing datas 17 (1.4)

3.2.2. Professional characteristics

Out of our 1,220 subjects, 626 (51.3%) held the position of captain. We had 743 (60.9%) pilots working for a national airline and 240 (19.7%) working for a low-cost airline. Among the entire sample, 505 (41.4%) worked in a city different from their place of residence. Regarding the type of operations, 551 (45.2%) crew members operated medium-haul flights, and 535 (43.9%) operated long-haul flights. In the studied population, 633 (51.9%) individuals worked between 40 and 70 h in the month preceding the questionnaire administration, and 635 (52.1%) were involved in multi-sector flights (Table 2).

Table 2.

Professional characteristics.

Subjects N = 1,220 (100%)
Status Captain 626 (51.3)
Copilot 571 (46.8)
Missing data 23 (1.9)
Permanent contract Yes 1,136 (93.1)
No 47 (3.9)
Missing data 37 (3)
Type of Arline Legacy airline 743 (60.9)
Low cost 240 (19.7)
Corporate 44 (3.6)
Cargo 43 (3.5)
Othera 114 (9.3)
Missing data 36 (3)
Working hours in the last thirty days Not worked 56 (4.6)
< 40 h 215 (17.6)
Between 40 and 70 h 633 (51.9)
> 70 h 264 (21.6)
Missing data 52 (4.3)
Commutingb Yes 505 (41.4)
No 638 (52.3)
Missing data 77 (6.3)
Permanent contract Yes 1,136 (93.1)
No 47 (3.9)
Missing data 37 (3.0)
Type of operations
Long haul flightc Yes 535 (43.9)
No 642 (52.6)
Missing data 43 (3.5)
Medium haul flightd Yes 551 (45.2)
No 626 (51.3)
Missing data 43 (3.5)
Regional flighte Yes 256 (21.0)
No 921 (75.5)
Missing data 43 (3.5)
Number of operations 1 1,021 (83.7)
> 1 156 (12.8)
Missing datas 43 (3.5)
Flight types
Night flight Yes 649 (53.2)
No 522 (42.8)
Missing data 49 (4.0)
Jet lag >3 h Yes 474 (38.9)
No 697 (57.1)
Missing data 49 (4.0)
Multi-sectors flightf Yes 635 (52.1)
No 536 (43.9)
Missing data 49 (4.0)
Flight to the east Yes 325 (26.7)
No 846 (69.3)
Missing data 49 (4.0)
Flight to the west Yes 410 (33.6)
No 761 (62.4)
Missing data 49 (4.0)
Number of flight types 1 type of flight 543 (44.5)
2 types of flight 203 (16.6)
3 types of flight 109 (8.9)
More than 3 types of flight 299 (24.5)
a

Sector of activity excluding public transport.

b

Place of work different from place of residence.

c

Long haul flight >3500 km.

d

Medium-haul flight: 1000–3500 km.

e

Regional flight: 0–1000 km.

f

Multi-sector flights characterized by multiple takeoffs and landings within a single workday and spanning several consecutive days.

3.2.3. Medical data

Out of the 1,220 individuals surveyed, 388 (31.8%) had at least one medical history, and 117 (9.6%) had a psychiatric history. Excluding the use of sleeping pills, 316 pilots (25.9%) reported taking medication in the last 30 days. The use of medication for insomnia was reported by 102 (8.4%) participants, with 18 (17.6%) of them reporting taking it more than twice a week. Only 3 (0.2%) pilots reported having attempted suicide, and 33 (2.7%) experienced suicidal thoughts in the past year. The average fatigue level on the numeric scale was 5.7 out of 10.

More than a third of the participants, 497 (40.1%) pilots, scored indicating alcohol misuse according to the AUDIT-C scale. Among them, 8 (0.7%) were dependent. On the other hand, only 9 (0.8%) reported cannabis use in the past year.

We noted that 179 (14.7%) respondents sought external help for psychological reasons in the past year. A significant proportion had consulted a psychiatrist and/or a psychologist, accounting for 114 individuals (10.7%).

Among all 1,220 participants, 153 (12.5%) reported feeling isolated in dealing with their psychological distress, and 346 (28.3%) did not want to disclose their psychological symptoms to their AME for fear of losing their Class I medical certificate. However, 659 (54.0%) were willing to report their symptoms if a procedure ensured no impact on their career (Table 3).

Table 3.

Medical datas.

Subjects N = 1,220 (100%)
Medical historya Yes 388 (31.8)
No 832 (68.2)
Psychiatric historyb Yes 117 (9.6)
No 1,103 (90.4)
Suicide attempt history Yes 3 (0.2)
No 1,066 (87.4)
Missing data 151 (12.4)
Suicidal thoughts within 12 months Yes 33 (2.7)
No 1,016 (83.3)
Missing data 171 (14.0)
Taking medication in the last 30 days Yes 316 (25.9)
No 803 (65.8)
Missing data 101 (8.3)
Use of medication for insomnia in the last 30 days Yes 102 (8.4)
No 1,009 (82.7)
Missing datas 109 (8.9)
Frequency of taking medication for insomnia < Once per week 47 (46.1)
1 to 2 times per week 35 (34.3)
More than twice per week 18 (17.6)
Missing data 2 (2.0)
AUDIT-Cc Safe use 524 (43.0)
Misuse 489 (40.1)
Dependence 8 (0.7)
Missing data 199 (16.3)
Cannabis consumption within 12 months Yes 9 (0.8)
No 1,063 (87.1)
Missing data 148 (12.1)
Numeric Scale Fatigue Mean (SD) 5.7/10 (2.3)
Missing data 132 (10.8)
Request for helpd for psychological reasons during the year Yes 179 (14.7)
No 887 (72.7)
Missing datas 154 (12.6)
Types of helps requested for psychological reasons during the year (many possible responses) Occupational physician and/or Aeromedical Examiner (AME) 21 (2.0)
General practitioner 71 (6.7)
Psychiatrist and / or psychologist 114 (10.7)
Website or online forums 8 (0.8)
Number of different types of aid requested during the year for psychological reasons 1 129 (12.1)
>2 39 (3.7)
Missing data 154
Failure to reporte symptoms for fear of loss of Classe I certificate Yes 346 (28.3)
No 626 (51.3)
Missing data 248 (20.4)
Declaratione of symptoms if no impact on fitness to fly Yes 659 (54.0)
No 188 (15.4)
Missing data 373 (30.6)
Feeling of isolation Yes 153 (12.5)
No 824 (67.5)
Missing data 243 (20.0)

Categorical variables are presented by N (%) and compared using Chi-Squared test and continuous variables by mean (SD) and compared using one-way ANOVA. The p-value is significant at p < 0.05.

a

Physical and/or psychiatric condition, self-reported and/or treated.

b

Self-reported and/or treated psychiatric condition.

c

AUDIT-C: Alcohol Use Disorders Identification Test (short version).

d

Includes occupational physician and/or aeromedical examiner or AME, general practitioner, psychiatrist and/or psychologist, website and/or online forum.

e

To the AME during the annual class I license renewal visit.

3.3. Comparative analysis of HAD-A and HAD-D profiles

3.3.1. Anxiety disorders (HAD-A)

In our study, 310 participants (25.4%) had an abnormal score on the HAD-A (HAD-A ≥ 8). Among them, 176 (14.4%) were identified with a score between 8 and 10 (suspected anxiety disorder) and 134 (11.0%) with a score higher than 10 (confirmed anxiety disorder) (Table 4).

Table 4.

Hospital anxiety and depression scale (HAD).

Sub-scale Interpretation Subjects N = 1,220 (100%)
HAD-A No symptoms (score < 8) 778 (63.8)
Suspected anxiety disorder (score between 8 and 10) 176 (14.4)
Confirmed anxiety disorder (score > 10) 134 (11.0)
Missing data 132 (10.8)
HAD-D No symptoms (score < 8) 932 (76.4)
Suspected depressive disorder (score between 8 and 10) 108 (8.9)
Confirmed depressive disorder (score > 10) 51 (4.2)
Missing data 129 (10.5)

In bivariate analysis, presented in Table 5, we observed a statistically significant association between different classes of HAD-A and sex (p = 0.025), marital status (p = 0.019), type of company (p = 0.002), hours worked in the last thirty days (p < 0.001), presence of financial difficulties (p < 0.001), presence of at least one medical history (p < 0.001), presence of psychiatric history (p < 0.001), use of insomnia medication (p < 0.001) and its frequency (p < 0.001), AUDIT-C score (p = 0.005), seeking help for psychological reasons during the year (p < 0.001), and feelings of isolation (p < 0.001). Additionally, there was a concurrent increase in self-reported fatigue scores on the numerical scale with the HAD-A score (p < 0.001).

Table 5.

Main results of the comparison of respondent profiles according to the HAD-A.

HAD-A
Variable No symptoms (score < 8)
N = 778 (71.5%)
Suspected anxiety disorder (score between 8 and 10)
N = 176 (16.2%)
Confirmed anxiety disorder (score ≥ 11)
N = 134 (12.3%)
P
Gender Female 60 (62.5) 16 (16.7) 20 (20.8) 0.025
Male 718 (72.4) 160 (16.1) 114 (11.5)
Age Mean (SD) 45.8 (9.6) 44.5 (9.7) 44.8 (9.3) 0.157
Nationality France 732 (71.1) 166 (16.3) 123 (12.0) 0.541
Europe (Except France) 45 (68.2) 10 (15.2) 11 (16.7)
Marital status Single 145 (65.3) 38 (17.1) 39 (17.6) 0.019
In a relationship 633 (73.3) 136 (15.7) 95 (11)
Type of airline Corporate 24 (54.5) 10 (22.7) 10 (22.7) 0.002
Cargo 25 (64.1) 8 (20.5) 6 (15.4)
Legacy 523 (75.7) 98 (14.2) 70 (10.1)
Low-Cost 150 (68.5) 35 (16.0) 34 (15.5)
Autrea 56 (58.9) 25 (26.3) 14(14.7)
Working hours in the last thirty days Not worked 23 (44.2) 12 (23.1) 17 (32.7) <0.001
<40 h 138 (70.8) 32 (16.4) 25 (12.8)
Between 40 et 70 h 447 (75.0) 95 (15.9) 54 (9.1)
>70 h 170 (69.4) 37 (15.1) 38 (15.5)
Financial difficulties Yes 84 (48.3) 37 (21.3) 53 (30.5) <0.001
No 656 (76.8) 122 (14.3) 76 (8.9)
Medical historyb Yes 233 (61.8) 61 (16.2) 83 (22.0) <0.001
No 545 (76.7) 115 (16.2) 51 (7.2)
Psychiatric historyc Yes 51 (44.7) 25 (21.9) 38 (33.3) <0.001
No 727 (74.6) 151 (15.5) 96 (9.9)
Suicidal thoughts within 12 months Yes 8 (24.2) 7 (21.2) 18 (54.5) <0.001
No 750 (74.0) 160 (15.8) 103 (10.2)
Use of regular medication Yes 199 (66.6) 48 (16.1) 52 (17.4) 0.004
No 572 (74.0) 123 (15.9) 78 (10.1)
Use of medication for insomnia Yes 48 (48.0) 23 (23.0) 29 (29.0) <0.001
No 725 (74.0) 152 (15.5) 103 (10.5)
Frequency of taking medication for insomnia < Once per week 27 (58.7) 12 (26.1) 7 (15.2) <0.001
1 to 2 times per week 17 (50.0) 9 (26.5) 8 (23.5)
More than twice per week 4 (22.2) 1 (5.6) 13 (72.2)
HAD-D No symptoms 738 (79.4) 137 (14.7) 55 (5.9) <0.001
Suspected disorder 33 (30.8) 31 (29.0) 43 (70.6)
Confirmed disorder 7 (13.7) 8 (15.7) 36 (70.6)
AUDIT-C Safe use 391 (74.8) 70 (13.4) 62 (11.9) 0.005
Misuse 344 (70.5) 87 (17.8) 57 (11.7)
Dependence 3 (37.5) 1 (12.5) 4 (50.0)
Cannabis consumption within 12 months Yes 4 (44.4) 3 (33.3) 2 (22.2) 0.186
No 763 (71.9) 169 (15.9) 129 (12.2)
Numeric Scale Fatigue Mean (SD) 5.2 (2.2) 6.7 (1.9) 7.5 (1.7) <0.001
Request for helpd for psychological reasons during the year Oui 70 (39.1) 55 (30.7) 54 (30.2) <0.001
Non 693 (78.3) 116 (13.1) 76 (8.6)
Failure to reporte symptoms for fear of loss of Class I certificate Oui 184 (53.3) 78 (22.6) 83 (24.1) <0.001
Non 509 (81.4) 77 (13.3) 39 (6.2)
Declaratione of symptoms if no impact on fitness to fly Oui 438 (66.7) 121 (18.4) 98 (14.9) 0.007
Non 147 (78.2) 26 (17.4) 15 (13.4)
Feeling of isolation Oui 48 (31.4) 37 (24.2) 68 (44.4) <0.001
Non 651 (79.2) 122 (14.8) 49 (6.0)

HAD-A: Hospital Anxiety and Depression Scale: Score for Anxiety, HAD-D: Hospital Anxiety and Depression Scale: Score for Depression. AUDIT-C: Alcohol Use Disorders Identification Test (short version), Categorical variables are presented by N (%) and compared using Chi-Squared Test and continuous variables by mean (SD) and compared using One-Way ANOVA. The p-value is significant at p < 0.05.

a

Sector of activity excluding public transport.

b

Physical and/or psychiatric condition, self-reported and/or treated.

c

Self-reported and/or treated psychiatric condition.

d

Includes occupational physician and/or Aeromedical examiner or AME, general practitioner, psychiatrist and/or psychologist, website and/or online forum.

e

To the AME during the annual Class I license renewal visit.

After including variables in a multivariate logistic regression model (Table 6), several factors remained significantly associated with the occurrence of an HAD-A score > 10 (confirmed anxiety disorder) compared to an HAD-A score < 8 (absence of symptoms). These factors included female gender (OR: 4.54 [2.00–10.35], p < 0.001), long-term medication use (OR: 2.82 [1.58–5.05], p < 0.001), feelings of isolation (OR: 4.49 [2.36–8.52], p < 0.001), engagement in multi-sector flights (OR: 1.81 [1.00–3.27], p = 0.05), abnormal HAD-D score (OR: 1.54 [1.38–1.72], p < 0.001), and fatigue score (OR: 1.44 [1.21–1.72], p < 0.001). However, working more than 40 h seemed to protect against the occurrence of a confirmed anxiety disorder (OR: 0.43 [0.20–0.95], p = 0.037, for the 40-70-h time range, and OR: 0.39 [0.16–0.98], p = 0.045 for the >70-h range).

Table 6.

HAD-A multivariate analysis.

Variable Comparison Odds ratio [IC 95%] p
Suspected anxiety disorder versus no symptoms Gender Female–Male 1.65 [0.80–3.43] 0.177
Financial difficulties Yes–No 1.50 [0.88–2.56] 0.141
HAD-D HAD_D 1.33 [1.22–1.45] < 0.001
Numeric Scale Fatigue NS Fatigue 1.26 [1.12–1.42] < 0.001
Feeling of isolation Yes–No 1.48 [0.82–2.68] 0.19
Multi-sector flights Yes–No 1.98 [1.27–3.06] 0.002
Failure to report symptoms for fear of loss of Classe I certificate Yes–No 1.97 [1.27–3.05] 0.002
Working hours in the last thirty days Not worked – < 40 h 2.58 [0.94–7.11] 0.066
Between 40 h and 70 h – < 40 h 0.81 [0.45–1.47] 0.489
> 70 h – < 40 h 0.64 [0.31–1.30] 0.217
Use of regular medication Oui–Non 1.02 [0.65–1.60] 0.939
Confirmed anxiety disorder versus no symptoms Gender Female–Male 4.54 [2.00–10.35] < 0.001
Financial difficulties Yes-No 1.90 [0.97–3.71] 0.061
HAD-D HAD_D 1.54 [1.38–1.72] < 0.001
Numeric scale fatigue NS Fatigue 1.44 [1.21–1.72] < 0.001
Feeling of isolation Yes–No 4.49 [2.36–8.52] < 0.001
Multi-sector flights Yes–No 1.81 [1.00–3.27] 0.05
Non reporting symptoms to AME Yes–No 2.67 [1.48–4.80] 0.001
Working hours in the last thirty days Not worked – < 40 h 2.49 [0.73–8.54] 0.146
Between 40 h and 70 h – < 40 h 0.43 [0.20–0.95] 0.037
> 70 h – < 40 h 0.39 [0.16–0.98] 0.045
Use of regular medication Yes–No 2.82 [1.58–5.05] < 0.001

Multinomial logistic regression model. Comparison: on the left the compared level and on the right the reference level. HAD-A: Hospital Anxiety and Depression Scale: Score for Anxiety, HAD-D: Hospital Anxiety and Depression Scale: Score for Depression, EN: Numerical Scale. Significant p value < 0.05.

We also found several factors significantly associated with the occurrence of an HAD-A score between 8 and 10 (suspected anxiety disorder) compared to the absence of symptoms. These factors included engagement in multi-leg flights (OR: 1.98 [1.27–3.06], p = 0.002), abnormal HAD-D score (OR: 1.33 [1.22–1.45], p < 0.001), and fatigue (OR: 1.26 [1.12–1.42], p < 0.001).

3.3.2. Depressive disorders (HAD-D)

In our sample, 159 (13.1%) individuals had an abnormal score on the HAD-D (HAD-D ≥ 8). Among them, 108 (8.9%) were identified with a score between 8 and 10 (suspected depressive symptoms) and 51 (4.2%) with a score > 10 (confirmed depressive symptoms) (Table 4).

In Table 7, the bivariate analysis revealed significant associations between various HAD-D categories and factors including nationality (p = 0.05), type of company (p = 0.017), working hours (p < 0.001), financial difficulties (p < 0.001), medical history (p < 0.001), psychiatric history (p < 0.001), use of insomnia medication and its frequency (p < 0.001, p = 0.001), AUDIT-C score (p = 0.02), and feelings of isolation (p < 0.001). Like HAD-A, there was a concurrent increase in self-rated fatigue scores on the numeric scale with rising HAD-D scores (p < 0.001).

Table 7.

Main results of the comparison of respondent profiles according to the HAD-D.

HAD-D
Variable No symptoms (score < 8)
N = 932 (85.4%)
Suspected depressive disorder (score between 8 and 10)
N = 108 (9.9%)
Confirmed depressive disorder (score > 10)
N = 51 (4.7%)
P
Gender Female 82 (85.4) 13 (13.5) 1 (1.0) 0.112
Male 850 (85.4) 95 (9.5) 50 (5.0)
Age Mean (SD) 45.6 (9.7) 44.8 (9.2) 45.2 (9.0) 0.680
Nationality France 881 (86.2) 94 (9.3) 46 (4.5) 0.005
Europe (except France) 50 (72.7) 14 (19.7) 5 (7.6)
Marital status Single 189 (84.8) 23 (10.3) 11 (4.9) 0.953
In a relationship 741 (85.6) 85 (9.8) 40 (4.6)
Type of airline Corporate 34 (77.3) 6 (13.6) 4 (9.1) 0.017
Cargo 32 (80.0) 5 (12.5) 3 (7.5)
Legacy 615 (88.7) 56 (8.1) 22 (3.2)
Low-Cost 174 (79.5) 29 (12.2) 16 (7.3)
Othera 77 (88.1) 12 (12.6) 6 (6.3)
Working hours in the last thirty days Not worked 35 (67.3) 10 (19.2) 7 (13.7) <0.001
<40 h 172 (87.8) 20 (10.2) 4 (2.0)
Between 40 et 70 h 525 (87.8) 54 (9.0) 19 (3.2)
>70 h 200 (81.6) 24 (9.8) 21 (8.6)
Financial difficulties Yes 116 (66.7) 34 (19.5) 24 (13.8) <0.001
No 766 (89.4) 67 (7.8) 24 (2.8)
Medical historyb Yes 291 (77.0) 60 (15.9) 27 (7.1) <0.001
No 641 (89.9) 48 (6.7) 24 (3.4)
Psychiatric historyc Yes 72 (63.2) 25 (21.9) 17 (14.9) <0.001
No 860 (88.0) 83 (8.5) 34 (3.5)
Use of regular medication Yes 243 (81.0) 42 (14.0) 15 (5.0) 0.013
No 677 (87.4) 63 (8.1) 35 (4.5)
Use of medication for insomnia Yes 68 (68.0) 22 (22.0) 10 (10.0) <0.001
No 858 (87.3) 86 (8.7) 39 (4.0)
Frequency of taking medication for insomnia < Once per week 37 (80.4) 6 (13.0) 3 (6.5) 0.001
1 to 2 times per week 23 (67.6) 10 (29.4) 1 (2.9)
More than twice per week 7 (38.9) 5 (27.8) 6 (33.3)
HAD-A No symptoms 738 (94.9) 33 (4.2) 7 (0.9) <0.001
Suspected disorder 137 (77.8) 31 (17.6) 8 (4.5)
Confirmed disorder 55 (41.0) 43 (32.1) 36 (26.9)
Numeric scale fatigue Mean (SD) 5.5 (2.2) 7.1 (1.8) 8.0 (1.5) <0.001
Suicidal thoughts within 12 months Yes 12 (36.4) 9 (27.3) 12 (36.4) <0.001
No 892 (87.8) 90 (8.9) 34 (3.3)
AUDIT-C Safe use 462 (88.3) 42 (8.0) 20 (3.8) 0.020
Misuse 411 (84.0) 54 (11.0) 24 (4.9)
Dependence 5 (62.5) 1 (12.5) 2 (25.0)
Cannabis consumption within 12 months Yes 7 (77.8) 2 (22.2) 0 (0.0) 0.396
No 907 (85.3) 105 (9.9) 51 (4.8)
Request for helpd for psychological reasons during the year Yes 115 (64.2) 47 (26.3) 17 (9.5) <0.001
No 794 (89.5) 59 (6.7) 34 (3.8)
Feeling of isolation Yes 83 (54.2) 42 (27.5) 28 (18.3) <0.001
No 752 (91.3) 54 (6.6) 18 (2.2)
Failure to reporte symptoms for fear of loss of Class I certificate Yes 250 (72.3) 58 (16.8) 38 (11.0) <0.001
No 576 (92.0) 39 (6.2) 11 (1.8)
Declaratione of symptoms if no impact on fitness to fly Yes 545 (82.7) 77 (11.7) 37 (5.6) 0.319
No 164 (87.2) 17 (9.0) 7 (3.7)

HAD-A: Hospital Anxiety and Depression Scale: Score for Anxiety, HAD-D: Hospital Anxiety and Depression Scale: Score for Depression. AUDIT-C: Alcohol Use Disorders Identification Test (short version), categorical variables are presented by N (%) and compared using Chi-Squared test and continuous variables by mean (SD) and compared using one-way ANOVA. The p-value is significant at p < 0.05.

a

Sector of activity excluding public transport.

b

Physical and/or psychiatric condition, self-reported and/or treated.

c

Self-reported and/or treated psychiatric condition.

d

Includes occupational physician and/or aeromedical examiner or AME, general practitioner, psychiatrist and/or psychologist, website and/or online forum.

e

To the AME during the annual class I license renewal visit.

After including the variables in a multivariate logistic regression model (Table 8), several factors remained significantly associated with the occurrence of an HAD-D score > 10 (confirmed depressive symptoms) compared to an HAD-D score < 8 (absence of symptoms). These factors included European nationality excluding France (odds ratio: 7.91 [2.15–31.79], p = 0.002), presence of suicidal ideation in the past year (OR: 4.40 [1.07–18.13], p = 0.04), presence of financial difficulties (OR: 3.41 [1.37–8.48], p = 0.008), fatigue (OR: 1.89 [1.35–2.63], p < 0.001), and abnormal HAD-A score (OR: 1.48 [1.28–1.71], p < 0.001). On the other hand, taking medication for insomnia (0.18 [0.033–0.98], p = 0.047) and consulting a general practitioner for psychological reasons (OR: 0.12 [0.02–0.66], p = 0.015) seemed to protect against confirmed depressive symptoms.

Table 8.

HAD-D multivariate analysis.

Variable Comparison Odds Ratio [IC 95%] p
Suspected depressive disorder versus no symptoms Consultation with a general practitioner (GP) Yes – No 1.28 [0.50–3.27] 0.602
Feeling of isolation Yes – No 2.78 [1.49–5.17] 0.001
HAD-A HAD-A 1.24 [1.14–1.36] < 0.001
Numeric Scale Fatigue NS Fatigue 1.24 [1.06–1.45] 0.008
Financial difficulties Yes – No 2.40 [1.29–4.48] 0.006
Nationality EU – FR 4.90 [2.10–11.40] < 0.001
Single Yes – No 0.46 [0.23–0.95] 0.037
Use of regular medication Yes – No 3.26 [1.04–10.20] 0.042
Use of medication for insomnia Yes – No 0.40 [0.12–1.26] 0.116
Suicidal thoughts within 12 months Yes – No 2.05 [0.62–6.73] 0.237
No help requested for psychological reasons Yes – No 0.38 [0.18–0.82] 0.013
Confirmed depressive disorder versus no symptoms Consultation with a GP Yes – No 0.12 [0.02–0.66] 0.015
Feeling of isolation Yes – No 3.68 [1.42–9.52] 0.007
HAD-A HAD- A 1.48 [1.28–1.71] < 0.001
Numeric Scale Fatigue NS Fatigue 1.89 [1.35–2.63] < 0.001
Financial difficulties Yes – No 3.41 [1.37–8.48] 0.008
Nationality UE – FR 7.91 [2.15–31.79] 0.002
Single Yes – No 0.35 [0.11–1.08] 0.068
Use of regular medication Yes – No 4.11 [0.80–21.06] 0.09
Use of medication for insomnia Yes – No 0.18 [0.033–0.98] 0.047
Suicidal thoughts within 12 months Yes – No 4.40 [1.07–18.13] 0.04
No help requested for psychological reasons Yes – No 0.32 [0.11–0.92] 0.035

Multinomial logistic regression model. Comparison: on the left the compared level and on the right the reference level. HAD-A: Hospital Anxiety and Depression Scale: Score for Anxiety, HAD-D: Hospital Anxiety and Depression Scale: Score for Depression, EN: Echelle Numérique. p value significative < 0.05.

We also found several factors significantly associated with an HAD-D score between 8 and 10 (suspected depressive symptoms) compared to the absence of symptoms. These factors included nationality (OR: 4.90 [2.10–11.40], p < 0.001), long-term medication use (OR: 3.26 [1.04–10.20], p = 0.042), presence of financial difficulties (OR: 2.40 [1.29–4.48], p = 0.006), fatigue (1.24 [1.06–1.45], p = 0.008), and abnormal HAD-A score (1.24 [1.14–1.36], p < 0.001). On the other hand, being unmarried seemed to protect against the occurrence of suspected depressive symptoms (OR: 0.46 [0.23–0.95], p = 0.037).

4. Discussion

To date, this work is the first descriptive study focusing on the mental health of airline pilots in Europe. With its 1,220 participants, it provides a significant sample describing anxiety and depressive disorders within this population.

Our findings regarding depressive disorders compare closely to those of the largest investigation conducted on this subject in 2016 by Wu et al. This observational cross-sectional study using an anonymous self-survey showed that 233 (12.6%) out of the 1848 airline pilots surveyed had depressive symptoms (8). The authors used the PHQ-9 (Patient Health Questionnaire-9) as a screening instrument for depression with a threshold of 10, which is comparable to the threshold of 8 used in the HAD-S (14). A New Zealand study on the health of technical flight crew showed that out of 856 airline pilots surveyed, only 11 (1.9%) reported suffering from depression and 6 (1%) from anxiety. However, this study was not anonymous, and the authors acknowledged that the prevalence of anxiety and depression were likely underestimated due to the risk of flight disqualification (15).

According to the latest survey by Public Health France in September 2022, during the period of our study, among individuals in the higher socioeconomic category, 15.2% of respondents reported a score > 10 on the HAD-D scale. Regarding anxiety, 22.4% had an HAD-A score > 10 (16). The score of confirmed anxiety or depressive disorders in our sample of airline pilots is therefore lower than that found in the French population.

Among the surveyed pilots, 33 (2.7%) reported suicidal thoughts in the past year. In the scientific literature, there is very little data on the prevalence of suicidal thoughts among airline pilots. An analysis of airplane accident reports in the United States from 1993 to 2012 estimated that out of 7,244 fatal accidents, 24 (0.33%) were caused by pilot suicide (17). However, this study only considered completed suicides and not the prevalence of suicidal thoughts. The most recent data on suicidal thoughts among airline pilots comes from the study by Wu et al. (8). They showed that the prevalence of suicidal thoughts was 4.1% in their sample, which is comparable to the rate found in our population.

Among the socio-professional characteristics, we found that multi-sector flights increase the risk of confirmed anxiety disorders (HAD-A > 10) by nearly 2. Multi-sector flights, involve multiple trips within the same working day. This type of flight is demanding due to time pressure and the repetition of takeoff and landing phases, where the pilot’s cognitive load is highest (18). The work by Feijó et al. (19) showed that workload increased the risk of developing common mental disorders (CMD), including anxiety.

One of the most concerning findings of our study is the high prevalence of alcohol misuse among airline pilots. More than one-third of the sample (489 pilots or 40.1%) had an AUDIT-C score indicating risky alcohol use, and 8 (0.7%) met the criteria for alcohol dependence. Notably, 57% of pilots with confirmed depressive disorders (HAD-D > 10) reported alcohol misuse. These findings align with previous research indicating a strong association between alcohol consumption and mental health disorders. According to the French Society of Addiction Medicine, over one-third of individuals with alcohol misuse will experience a psychiatric comorbidity during their lifetime, particularly depression and anxiety disorders (20). There is a continuum between these different forms of use.

Our study shows a correlation between HAD-S scores and alcohol misuse in bivariate analysis. The links between mental health and alcohol have been extensively described in the scientific literature. According to the French Society of Addiction Medicine, over one-third of individuals with alcohol misuse will experience a psychiatric comorbidity during their lifetime, particularly depression and anxiety disorders (20). The anxiolytic properties of alcohol make it a commonly used substance among individuals with anxiety and depressive disorders, but chronic consumption exacerbates psychiatric symptoms over time (21). Some countries, such as Japan, already mandate pre-flight breathalyzer tests for pilots (22). Introducing such measures across more jurisdictions could help mitigate immediate risks related to acute alcohol consumption. Additionally, for chronic alcohol use, biological markers such as carbohydrate-deficient transferrin (CDT), mean corpuscular volume (MCV) and the gamma glutamyl transferase (GGT) markers could be implemented for systematic annual screening. These markers are a well-established biomarker for chronic alcohol consumption (23). Establishing standardized guidelines for marker normalization before a pilot is deemed fit to fly could enhance safety while promoting rehabilitation.

On the other hand, only 9 (0.8%) participants reported using cannabis in the past year. The low number of users could be explained by the implementation of random drug screening following the Germanwings accident in 2015 (4) and the slow elimination of tetrahydrocannabinol (THC), the psychoactive substance in cannabis (24).

We showed that the self-rated average fatigue on a numerical scale was 5.7/10. Several reasons can explain the observed links between fatigue and anxiety-depressive disorders in our study. “Jet lag” is common among pilots. Its manifestations include fatigue, irritability, and sometimes moderate depression (25). Working irregular hours increases the risk of depressive pathology (26). Finally, fatigue is one of the criteria for a major depressive episode according to the DSM-V (27).

In our study, 102 (8.4%) subjects reported taking medication for insomnia. Among them, 47 (46.1%) took it less than once a week, 35 (34.3%) took it 1 to 2 times a week, and 18 (17.6%) took it more than twice a week. Due to their profession, pilots are prone to insomnia. The links between insomnia and depression are complex. Insomnia is both a symptom and a risk factor for the onset of depression (28). Insomnia is included in the diagnostic criteria for a major depressive episode in the DSM-V (27). Conversely, fragmented sleep is accompanied by a stress reaction with hypothalamo-pituitary hyperactivation and carries a high risk of depression (28). Our study showed that taking insomnia medication more than twice a week was protective against a score of HAD-D > 10 (confirmed depressive disorder) (OR: 0.18).

However, the treatment of sleep disorders in airline pilots, should be approached with caution. Certain medication classes, such as benzodiazepine-type hypnotics, can affect cognitive performance and cause sedation. With chronic use, dependence is even possible. The same applies to sedating antihistamines, one of which is available over the counter in France, which can also cause sedation and cognitive impairments (29). Non-pharmacological strategies could be of interest in this population, such as cognitive-behavioral therapy, which has shown its effectiveness in chronic insomnia (29). It is also important to note that the prevention of insomnia and fatigue in airline pilots should consider the risk factors associated with their work. Prevention strategies can be implemented. Further studies on the subject would be interesting to determine the characteristics of insomnia in this population and its contributing factors.

Being of foreign nationality increased the risk of developing a confirmed depressive disorder (score of HAD-D > 10) by almost 8 times. Several studies conducted in populations of expatriate workers have shown that they are at risk of developing anxiety and/or depression-related mental disorders (30).

The risk of unfitness for duty acts as a barrier to reporting psychological symptoms to AME (8, 19). Our study showed that 659 (54.0%) pilots would be willing to report these symptoms provided that a procedure guarantees no impact on their career. As suggested by the BEA is in its report on the Germanwings crash (1), the self-declaration of anxiety and depressive symptoms to AME could be strengthened by mitigating the socio-economic risks associated with flight unfitness.

In close comparison to the study by Wu et al. (8), limitations of this work include a potential underestimation of the score of anxiety and/or depression due to a possible lower participation rate among individuals with more severe disorders compared to those without. This may have led to an underestimation of the true score of depression and anxiety during the survey period. Conversely, an upward bias may have occurred if individuals with these disorders were more likely to participate in the survey than those without symptomatology due to their familiarity with the study’s objective (8).

Another limitation of our study was the lack of statistical representativeness of our sample compared to the target population. We found a significant difference in terms of gender and job function. However, there was no significant difference in terms of the proportion of fixed-term contracts (CDD) and age. This lack of representativeness makes the results non-generalisable to the entire population of pilots affiliated with SNPL or even to the general population of airline pilots.

Although the HAD-S is a validated scale for screening anxiety and depression, it would be useful to propose medical interviews to confirm the diagnoses of anxiety and depressive disorders.

5. Conclusion

This study represents a major advancement in understanding the mental health of European airline pilots. Despite anxiety and depression levels are lower than those observed in higher socioeconomic categories in France, the results indicate that a significant proportion of pilots suffer from psychological symptoms. This work highlights the need to implement prevention programs targeting profiles at risk of developing anxiety and/or depressive disorders. Our study also showed that a large proportion of subjects exhibited alcohol misuse, which requires prevention efforts to reduce health risks. However, it is crucial to first establish measures aimed at mitigating the socio-economic risks associated with the loss of a license for medical reasons to encourage the self-reporting of anxiety and/or depressive symptoms to the AME. In the future, conducting longitudinal studies would be relevant to further strengthen our knowledge on this topic, which is rarely addressed in the scientific literature.

Funding Statement

The author(s) declare that financial support was received for the research and/or publication of this article. This study was supported by the Public Health Department of the University Hospital of Nice.

Data availability statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Ethics statement

The studies involving humans were approved by COMITE DE PROTECTION DES PERSONNES NORD OUEST III CHU-Niveau 03-Porte 03-363-Avenue de la Côte de Nacre14033 Caen Cedex 09, France. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.

Author contributions

MP: Conceptualization, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing. BP-K: Conceptualization, Investigation, Methodology, Project administration, Supervision, Validation, Visualization, Writing – review & editing. JA: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Software, Supervision, Writing – review & editing. MB: Writing – review & editing. CP: Funding acquisition, Resources, Supervision, Validation, Writing – review & editing.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declare that no Gen AI was used in the creation of this manuscript.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

  • 1.Bureau d’Enquêtes et d’Analyse . Final report–Germanwings Airbus A320-211 (D-AIPX) accident 24 march 2015–BEA2015-0125.En. (2016). Available online at: https://www.bea.aero/uploads/tx_elydbrapports/BEA2015-0125.en-LR.pdf
  • 2.National Transportation Safety Committee . Aircraft accident report SilkAir flight MI 185. Palembang: Department of Communications Republic of Indonesia; (1980). [Google Scholar]
  • 3.European Union Aviation Safety Agency . Easy Access Rules for Medical Requirements [Internet] (2020). Available online at: https://www.easa.europa.eu/sites/default/files/dfu/Easy_Access_Rules_for_Medical_Requirements.pdf
  • 4.Cullen P, Cahill J, Gaynor K. A qualitative study exploring well-being and the potential impact of work-related stress among commercial airline pilots. Aviat Psychol Appl Hum Fact. (2021) 11:1–12. doi: 10.1027/2192-0923/a000199 [DOI] [Google Scholar]
  • 5.Hoffman WR, Patel PK, Aden J, Willis A, Acker JP, Bjerke E, et al. Multinational comparison study of aircraft pilot healthcare avoidance behaviour. Occup Med. (2023) 73:434–8. doi: 10.1093/occmed/kqad091, PMID: [DOI] [PubMed] [Google Scholar]
  • 6.Sen A, Akin A, Canfield DV. Chaturvedi AK. Medical histories of 61 aviation accident pilots with postmortem SSRI antidepressant residues. ASEM. (2007) 78:1055–9. doi: 10.3357/ASEM.2030.2007 [DOI] [PubMed] [Google Scholar]
  • 7.Cross DS, Wallace R, Cross J, Coimbra Mendonca F. Understanding pilots’ perceptions of mental health issues: a qualitative phenomenological investigation among airline pilots in the United States. Cureus. (2024). Available online at: https://www.cureus.com/articles/276591-understanding-pilots-perceptions-of-mental-health-issues-a-qualitative-phenomenological-investigation-among-airline-pilots-in-the-united-states [DOI] [PMC free article] [PubMed]
  • 8.Wu AC, Donnelly-McLay D, Weisskopf MG, McNeely E, Betancourt TS, Allen JG. Airplane pilot mental health and suicidal thoughts: a cross-sectional descriptive study via anonymous web-based survey. Environ Health. (2016) 15:121. doi: 10.1186/s12940-016-0200-6, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Caisse de Retraite du Personnel Navigant . Chiffres clés. (2018). Available online at: https://www.crpn.fr/la-crpn/chiffres-cles/
  • 10.SNPL . Available online at: https://snpl.com
  • 11.Bocéréan C, Dupret E. A validation study of the hospital anxiety and depression scale (HADS) in a large sample of French employees. BMC Psychiatry. (2014) 14:354. doi: 10.1186/s12888-014-0354-0, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Gache P, Michaud P, Landry U, Accietto C, Arfaoui S, Wenger O, et al. The alcohol use disorders identification test (AUDIT) as a screening tool for excessive drinking in primary care: reliability and validity of a French version: alcoholism. Clin Exp Res. (2005) 29:2001–7. doi: 10.1097/01.alc.0000187034.58955.64, PMID: [DOI] [PubMed] [Google Scholar]
  • 13.Observatoire Français des Drogues et des Tendances addictives. Détection des usages problématiques de cannabis: le Cannabis Abuse Screening Test (CAST). (2013). Available online at: https://www.ofdt.fr/publications/collections/notes/detection-des-usages-problematiques-de-cannabis-le-cannabis-abuse-screening-test-cast
  • 14.Hansson M, Chotai J, Nordstöm A, Bodlund O. Comparison of two self-rating scales to detect depression: HADS and PHQ-9. Br J Gen Pract. (2009) 59:e283–8. doi: 10.3399/bjgp09X454070, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Sykes AJ, Larsen PD, Griffiths RF, Aldington S. A study of airline pilot morbidity. Aviat Space Environ Med. (2012) 83:1001–5. doi: 10.3357/ASEM.3380.2012, PMID: [DOI] [PubMed] [Google Scholar]
  • 16.Santé Publique France . CoviPrev: une enquête pour suivre l’évolution des comportements et de la santé mentale pendant l’épidémie de COVID-19 [Internet]. Available online at: https://www.santepubliquefrance.fr/etudes-et-enquetes/coviprev-une-enquete-pour-suivre-l-evolution-des-comportements-et-de-la-sante-mentale-pendant-l-epidemie-de-covid-19#block-249162
  • 17.Vuorio A, Laukkala T, Navathe P, Budowle B, Eyre A, Sajantila A. Aircraft-assisted pilot suicides: lessons to be learned. Aviat Space Environ Med. (2014) 85:841–6. doi: 10.3357/ASEM.4000.2014, PMID: [DOI] [PubMed] [Google Scholar]
  • 18.François M, Liévin D, Mouzé-Amady M. Activité, charge de travail et stress du personnel navigant des compagnies aérienne: la situation dans les courts et moyens courriers. INRS. (2007); Documents pour le Médecin du Travail (111): 307–333.
  • 19.Feijó D, Luiz RR, Camara VM. Common mental disorders among civil aviation pilots. Aviat Space Environ Med. (2012) 83:509–13. doi: 10.3357/ASEM.3185.2012, PMID: [DOI] [PubMed] [Google Scholar]
  • 20.Société Française d’Alcoologie – SFA . Mésusage de l’alcool dépistage, diagnostic et traitement Recommandation de bonne pratique. Alcoologie et Addictologie. (2015) 37:5–84. [Google Scholar]
  • 21.Guelfi JD, Rouillon F, Mallet L. Manuel de psychiatrie. 4e éd ed. Issy-les-Moulineaux: Elsevier Masson; (2021). [Google Scholar]
  • 22.Flight Standards Division, Airworthiness division aviation safety and security department, Japan civil aviation bureau, Ministry of Land, infrastructure, Transport and Tourism . Guidelines for implementation of alcohol testing for flight crew etc. (2019). Available at: https://www.mlit.go.jp/koku/15_hf_000035.html
  • 23.Meerkerk G-J, Njoo KH, Bongers IMB, Trienekens P, Van Oers JAM. Comparing the diagnostic accuracy of carbohydrate-deficient transferrin, γ-Glutamyltransferase, and mean cell volume in a general practice population. Alcohol Clin Exp Res. (1999) 23:1052–9. doi: 10.1111/j.1530-0277.1999.tb04224.x, PMID: [DOI] [PubMed] [Google Scholar]
  • 24.Karschner EL, Schwilke EW, Lowe RH, Darwin WD, Herning RI, Cadet JL, et al. Implications of plasma 9-tetrahydrocannabinol, 11-Hydroxy-THC, and 11-nor-9-Carboxy-THC concentrations in chronic Cannabis smokers. J Anal Toxicol. (2009) 33:469–77. doi: 10.1093/jat/33.8.469, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Katz G, Durst R, Zislin Y, Barel Y, Knobler HY. Psychiatric aspects of jet lag: review and hypothesis. Med Hypotheses. (2001) 56:20–3. doi: 10.1054/mehy.2000.1094 PMID: [DOI] [PubMed] [Google Scholar]
  • 26.Nakata A, Haratani T, Takahashi M, Kawakami N, Arito H, Kobayashi F, et al. Association of Sickness Absence with poor sleep and depressive symptoms in shift workers. Chronobiol Int. (2004) 21:899–912. doi: 10.1081/CBI-200038104, PMID: [DOI] [PubMed] [Google Scholar]
  • 27.American Psychiatric Association . American Psychiatric Association, éditeurs. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Washington, D.C.: American Psychiatric Association; (2013). 947 p. [Google Scholar]
  • 28.Royant-Parola S. Insomnie et dépression. Annales Médico-psychologiques, revue psychiatrique. (2012) (cité 26 mars 2023); 170(3): 198–201. Available online at: https://linkinghub.elsevier.com/retrieve/pii/S0003448712000777
  • 29.Haute Autorité de Santé . Prise en charge du patient adulte se plaignant d’insomnie en médecine générale. Saint-Denis La Plaine: HAS. (2006). Available at: https://www.has-sante.fr/jcms/c_522637/fr/prise-en-charge-du-patient-adulte-se-plaignant-d-insomnie-en-medecine-generale
  • 30.Foyle MF, Beer MD, Watson JP. Expatriate mental health. Acta Psychiatr Scand. (1998) 97:278–83. doi: 10.1111/j.1600-0447.1998.tb10000.x PMID: [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.


Articles from Frontiers in Public Health are provided here courtesy of Frontiers Media SA

RESOURCES